Evidence map›Paper›PMID 37881802›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2023

[Evaluation of a change in the serological diagnostic algorithm for Chagas disease in ColombiaAvaliação da mudança do algoritmo de diagnóstico sorológico da doença de Chagas na Colômbia].

Andrea Rosana Marchiol, Rafael Herazo, Carolina Flórez Sánchez, Martha Stella Ayala Sotelo, Maryi Lorena Segura, Liliana Jazmín Cortés Cortés, Ricardo Andrés Caicedo Díaz

Open access · diamondAbstract readEnglish Abstract
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 73% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Andrea Rosana MarchiolDrugs for Neglected Diseases initiative Rio de Janeiro Brasil Drugs for Neglected Diseases initiative, Rio de Janeiro, Brasil.
Rafael HerazoDrugs for Neglected Diseases initiative Rio de Janeiro Brasil Drugs for Neglected Diseases initiative, Rio de Janeiro, Brasil.
Carolina Flórez SánchezInstituto Nacional de Salud Bogotá Colombia Instituto Nacional de Salud, Bogotá, Colombia.
Martha Stella Ayala SoteloInstituto Nacional de Salud Bogotá Colombia Instituto Nacional de Salud, Bogotá, Colombia.
Maryi Lorena SeguraInstituto Nacional de Salud Bogotá Colombia Instituto Nacional de Salud, Bogotá, Colombia.
Liliana Jazmín Cortés CortésInstituto Nacional de Salud Bogotá Colombia Instituto Nacional de Salud, Bogotá, Colombia.
Ricardo Andrés Caicedo DíazDrugs for Neglected Diseases initiative Rio de Janeiro Brasil Drugs for Neglected Diseases initiative, Rio de Janeiro, Brasil.
Instituto Nacional de Salud · CODrugs for Neglected Diseases Initiative · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the effects of changing the algorithm for serological diagnosis of Methods: A descriptive, cross-sectional study was carried out, based on secondary sources between 2015 and 2021, consolidating the number of serological tests carried out by the laboratories. A survey was developed to identify benefits and limitations in the implementation of the new algorithm for serological diagnosis. Totals, proportions, and averages of the number of tests were estimated by comparing two different periods. Results: Information from 33 public health laboratories was analyzed, 87.9% of which processed serological assays during the period under study. The use of serological tests increased after the publication of the new guideline in 2017, and the capacity to perform the second test increased from four to 33 public health laboratories. In absolute terms, ELISAs for antigens and recombinant antigens became the most performed tests in Colombia after 2017. Conclusions: The change in the algorithm for serological diagnosis of Chagas disease in Colombia in 2017 had positive effects on access to diagnosis since it facilitated the use of the second test. This change resulted in increased diagnostic coverage. The country's laboratories have access to a simple, timely, quality algorithm that could be implemented in almost any clinical laboratory in the country.

Indexed as

Chagas diseaseColombiahealth services coverageserologic tests

Identifiers

PMID37881802
PMCPMC10597392
OpenAlexW4387902924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.